Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Betoptic S Generic Name & Formulations
Legal Class
Rx
General Description
Betaxolol HCl 0.25%; oph. susp; contains benzalkonium chloride.
Pharmacological Class
Cardioselective beta-blocker.
How Supplied
Susp—10mL, 15mL
Manufacturer
Generic Availability
NO
Betoptic S Indications
Indications
Open-angle glaucoma. Ocular hypertension.
Betoptic S Dosage and Administration
Adults and Children
Remove contact lenses before use; may reinsert 15mins after instillation. 1–2 drops twice daily.
Betoptic S Contraindications
Contraindications
Sinus bradycardia. Greater than 1st-degree AV block. Cardiogenic shock. Overt cardiac failure.
Betoptic S Boxed Warnings
Not Applicable
Betoptic S Warnings/Precautions
Warnings/Precautions
History of cardiac failure or heart block. Discontinue at 1st sign of cardiac failure. COPD. Asthma. Pulmonary impairment. Measure intraocular pressure during 1st month of treatment. Diabetes (esp. labile). Vascular insufficiency; consider alternative therapy if reduced cerebral blood flow or Raynaud's phenomenon develop. History of atopy or anaphylaxis. May mask hypoglycemia and hyperthyroidism. Discontinue before general anesthesia. Avoid abrupt cessation. Pregnancy. Nursing mothers.
Betoptic S Pharmacokinetics
See Literature
Betoptic S Interactions
Interactions
May potentiate or be potentiated by systemic β-blockers. May potentiate reserpine, hypoglycemics. May antagonize adrenergic psychotropics. Additive hypotension and/or marked bradycardia with concomitant calcium antagonists, antiarrhythmics, digitalis.
Betoptic S Adverse Reactions
Adverse Reactions
Transient discomfort, tearing. Rarely: decreased corneal sensitivity, erythema, itch, corneal punctate staining, keratitis, anisocoria, photophobia, depression, headache, bradycardia, dyspnea, hives.
Betoptic S Clinical Trials
See Literature
Betoptic S Note
Not Applicable
Betoptic S Patient Counseling
See Literature
